Lenadogene nolparvovec

DB16781InvestigationalGene Therapies

Lenadogene nolparvovec: Overview.

Code names
GS-010

Resolves to

Compound
UNIIX0R16875YDCAS1640969-63-6

What you can answer from here — as of April 23, 2025

6Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Lenadogene nolparvovec, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In